Position in GILD
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$422,733
+$44,344 QoQ
Shares Held
3,346
+23.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,461
of 2,266 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026New Republic Capital, LLC holds $13,477,197 across 11 Drug Manufacturers - General names. GILD ranks #10 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,001 | $3,599,489 | |
| 2 | JNJ |
Johnson & Johnson
|
8,090 | $2,054,617 | |
| 3 | AMGN |
Amgen Inc
|
4,966 | $1,798,287 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,402 | $1,465,157 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
17,698 | $1,019,758 | |
| 6 | ABBV |
AbbVie Inc.
|
3,936 | $990,455 | |
| 7 | PFE |
Pfizer Inc
|
25,574 | $615,821 | |
| 8 | NVS |
Novartis AG
|
3,729 | $584,408 |
All Filings in GILD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $422,733 | 3,346 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $378,389 | 2,715 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $486,786 | 3,966 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $219,003 | 1,973 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $213,535 | 1,926 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||